Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.78 USD | -2.73% | -1.66% | -17.02% |
Business Summary
Number of employees: 398
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Clinical Laboratory Goods
78.0
%
| 75 | 80.4 % | 58 | 78.0 % | -21.96% |
Point-of-Care
12.3
%
| 10 | 11.1 % | 9 | 12.3 % | -10.87% |
Clinical Laboratory Services
9.7
%
| 8 | 8.5 % | 7 | 9.7 % | -8.27% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Americas
67.5
%
| 67 | 72.3 % | 51 | 67.5 % | -24.89% |
Ireland
32.5
%
| 26 | 27.7 % | 24 | 32.5 % | -5.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Gillard
CEO | Chief Executive Officer | 43 | 17/20/17 |
Ronan O'Caoimh
FOU | Founder | 68 | 01/92/01 |
Cormac Reynolds
COO | Chief Operating Officer | - | 01/21/01 |
Eibhlin Kelly
CTO | Chief Tech/Sci/R&D Officer | 40 | 01/15/01 |
Gary Keating
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/22/01 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 26/22/26 |
Jim Walsh
BRD | Director/Board Member | 65 | 01/95/01 |
Nick O’Hare
SAM | Sales & Marketing | - | 01/22/01 |
Colm Molloy
HRO | Human Resources Officer | 53 | 01/21/01 |
Ian Wells
LAW | General Counsel | 55 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronan O'Caoimh
FOU | Founder | 68 | 01/92/01 |
Jim Walsh
BRD | Director/Board Member | 65 | 01/95/01 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 26/22/26 |
John Gillard
CEO | Chief Executive Officer | 43 | 17/20/17 |
Andrew Omidvar
BRD | Director/Board Member | - | 29/23/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 2 | 700,000 | 0 | 0 | 89.35 % |
Stock B | 1 | 33,077,257 | 30,181,196 ( 91.24 %) | 2,511,200 ( 7.592 %) |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-17.02% | 16.81M | |
+0.70% | 12.95B | |
-7.57% | 7.84B | |
+3.02% | 5.5B | |
+0.93% | 4.61B | |
+8.48% | 4.61B | |
+9.21% | 2.66B | |
-13.66% | 2.08B | |
-11.63% | 1.72B | |
+3.45% | 1.79B |
- Stock Market
- Equities
- TRIB Stock
- Company Trinity Biotech plc